## Note
nid: 1495595263141
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::24_Proteasomal_Inhibitors, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Pixorize::02_Biochem::22_Onc_Drugs::13_Bortezomib,_Carfilzomib, #AK_Step1_v11::#Pixorize::03_Pharm::11_Oncology::Bortezomib,_Carfilzomib, #AK_Step1_v11::#SketchyPharm::08_Antineoplastics::SmallMoleculeInhibitors(TyrosineKinase_ProteasomeInhibitors_CDKInhibitors), #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^FA_Updates::FA2017, #AK_Step1_v11::^Other::^HighYield::2-RelativelyHighYield
markdown: false

### Text
<div>
  Carfil<b>zomib</b> and Borte<b>zomib</b> are examples of
  antineoplastics that work by inhibiting the
  {{c1::<b>proteasome</b>}}
</div>

### Extra
<div>
  The Proteasome is an intracellular tagging system that allows for
  degradation of unwanted / used up / damaged compounds (ex.
  <b>pro-apoptotic proteins</b>)
</div>
<div><img src="18_12ProteasomeActivity-L.jpg" class=
"resizer"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy
#REF!

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_7.png"></a>
</div>

### Additional Resources


### One by one

